Reexamination of the marine sponge Suberea aff. praetensa, (Row) from the Gulf of Thailand furnished in addition to bromotyrosine derivatives found previously 5-bromo-and 5-chlorocavernicolin, cavernicolins 1 and 2, two other brominated tyrosine metabolites, a known bisoxazolidone and a new unusual rearranged tyrosine metabolite subereatensin. Several of the metabolites exhibited significant inhibitory effects against five human cancer cell lines.
Introduction
In an earlier article (Kijjoa et al., 2001) we described isolation of the bromotyrosine derivatives fistularin-3, agelorins A and B and the new 11,17-dideoxyagelorins A and B as well as clionasterol from a Gulf of Thailand collection of the marine sponge Suberea aff. praetensa (Row). The only other previous report on a Suberea species dealt with Suberea creba from the Coral Sea (Debitus, et al. 1998) . In order to obtain more material for biological tests we have now carried out two additional collections from the same locality. A collection of November 1999 furnished again clionasterol and fistularin-3 as well as 5-chloro-and 5-bromocavernicolin (1a and 2) previously isolated from Aplysia (Verongia) cavernicola (D'Ambrosio et al., 1984 , Guerriero et al., 1984 . A second col- § Dedicated to Professor Dr. Nuno R. Grande, founder of Instituto de Ciê ncias Biomé dicas de Abel Salazar, on the occasion of his 70 th birthday. and Rinehart, 1981) , and 4a (previously reported by Sharma and Burkholder, 1967 , from Verongia cauliformis and by Tymiak and Rinehart, 1985 , from Aplysina fistularis), the epimeric dibromolactams cavernicolin 1 (5) and cavernicolin 2 (6) earlier isolated from Aplysina cavernicola (D' Ambrosio et al., 1982) and the bis-oxazolidone 7a (see Chart 1), previously reported from Verongia lacunosa (Borders et al., 1974) and Aplysina fulva (Gopichand and Schmitz, 1979 ). An unusual new constituent was the rearranged tyrosine derivative 8 which we have named subereatensin. Acetate 1b, 4a and its acetate 4b exhibited significant inhibitory effects against five human cancer cell lines.
Materials and Methods

H and
13
C NMR spectra were recorded at ambient temperature on a Bruker AMC instrument operating at 300.13 and 75.47 MHz, respectively. EI mass spectra were measured on a Hitachi Perkin-Elmer RMV-6m instrument. For HRMS samples were run using +FAB ionization with Xe gas at GKV on a KRATOS CONCEPT III, 2 sector mass spectrometer. (Kijjoa et al., 2001) . The collections were frozen immediately at Ð20 ∞C for one night prior to extraction.
Extraction, isolation and characterization of the constituents
A. First extract. The sample (490 g fresh weight) was thawed, homogenized with EtOH (1.5 l), allowed to stand overnight in a dark chamber and filtered. The residue on the filter paper was reextracted twice with EtOH (1.5 l). The aqueous alcoholic extracts were combined,evaporated at reduced pressure to ca. 180 ml, and partitioned with EtOAc (3 ¥ 300 ml). The EtOAc solutions were combined and concentrated at reduced pressure to give a residue (5.8 g) which was chromatographed over Si gel (54 g) and eluted with petrol-CHCl 3 , CHCl 3 -Me 2 O and CHCl 3 -MeOH, 200 ml frs being collected as follows: Frs 1Ð4 (petrol-CHCl 3 , 7:3 v/v), 5Ð19 (petrol-CHCl 3 , 1:1), 20Ð31 (petrolCHCl 3 , 3:7), 32Ð42 (petrol-CHCl 3 , 1:9), 43Ð65 (CHCl 3 -Me 2 O, 9:1), 66Ð82 (CHCl 3 -Me 2 O, 7:3), 83Ð108 (CHCl 3 -Me 2 O, 1:1), 109Ð130 (CHCl 3 -Me 2 O, 1:9). Recrystallization of frs 23Ð28 (52 mg) from petrol and CHCl 3 gave clionasterol (23 mg) identified by MS and 1 H NMR spectrometry. Frs 49Ð57 (140 mg) on purification by PTLC (Si gel, CHCl 3 -Me 2 O-HCO 2 H, 70:30:0.1) gave fistularin-3 (32 mg) identified by comparison with material isolated previously (Kijjoa et al., 2001) , 5-bromocavernicolin (2, 18 mg) and 5-chlorocavernicolin (1a, 22 mg) identified by 1 H and 13 C NMR spectrometry, COSY, NOESY, HMBC, and by comparison with the literature (for 1a, D'Ambrosio et al., 1985 , for 2 Guerriero et al., 1984 (all structures in Fig. 1) .
B. Second extract. The sample (1.3 kg fresh weight) on homogenization with EtOH (2 l), filtration, two reextractions of the residue on the filter paper with EtOH, concentration of the combined filtrates to ca. 300 ml, partitioning with EtOAc (3 ¥ 500 ml) and concentration of the EtOAc layers at reduced pressure gave 32 g of crude extract which was chromatographed on Si gel (120 g) and eluted as before, 200 ml frs being collected as follows: Frs 1Ð13 (petrol-CHCl 3 , 3:2), 14Ð24 (petrol- Recrystallization of frs 40Ð46 (324 mg) from CHCl 3 -petrol gave 3a (153 mg) (Tymiak and Rinehart, 1985) further characterized as the acetate 3b. Recrystallization of frs 47Ð48 (222 mg) from CHCl 3 -Me 2 O gave 4a (57 mg) also characterized as the acetate (Sharma and Burkholder, 1970, Tymiak and Rinehart, 1985) ; the mother liquor on purification by PTLC (Si gel, CHCl 3 -Me 2 O-HCO 2 H) gave 51 mg of a mixture of cavernicolin 1 (5, major) and cavernicolin 2 (6, minor), identified by 1 H and 13 C NMR spectrometry, COSY, NOESY, HMBC and comparison with data in the literature (D'Ambrosio et al., 1982) , and 112 mg at a more polar fraction containing fistularin-3, agelorin A and agelorin B which were identified by comparison with the compounds obtained from Suberea aff. praetensa previously (Kijjoa et al., 2001) . Recrystallization of frs 51Ð54 (632 mg from CHCl 3 -Me 2 O afforded the bis-2-oxazolidone 7a (Fig. 2) (420 mg) previously reported from Verongia lacunosa (Borders et al., 1974) and Aplysina fistularis forma fulva (Gopichand and Schmitz, 1979) which was characterized by the new monoand diacetates 7b and 7c (Fig. 2, vide infra) . . Table I . The presence of a conjugated carbethoxy group was indicated by the signals of C-5 through C-9, H-5, H-8 and H-9 and the correlations shown in Table I ; H-5 was coupled to one of the signals in the two proton multiplet at δ 4.1Ð4.2 and attached to a carbon at δ 83.16 carrying an ethoxy group; the remaining signals and correlations were characteristic of the fivemembered amide ring of the various cavernicolins with a hydroxyl group on carbon-3a. A possible route to the formation of 8 may involve oxidative cleavage of a precursor of type 9 to 10 followed by an aldol condensation (Fig. 3) .
Cytotoxicity assays
a) Cell lines. Human tumor cell lines MCF-7 (breast), NCI-H460 (lung), SF-268 (CNS), TK-10 (renal) and UACC-62 (melanoma) were provided by the National Cancer Institute, Bethesda, MD. b) Cell growth assay. Stock solutions in DMSO were stored at Ð20 ∞C providing uniform samples for retests. The frozen concentrates were diluted to the desired concentration with the cell culture medium prior to the assays. Effects on the growth of human cancer cell lines were evaluated by the procedure adopted in the U. S. National Cancer Institute's in vitro anticancer drug screening program which uses the sulforhodamine B (SRB) assay to assess growth inhibition (Skehan et al., 1990) . Cells were routinely maintained as adherent cell cultures in RPMI-1640 medium containing 5% heat-inactivated fetal bovine serum, 2 mm glu-tamine and 50 µg/ml gentamycin at 37 ∞C in a humidified atmosphere containing 5% CO 2 . For the SRB assay each cell line was plated at the density ensuring exponential growth throughout the period of the experiment (according to the growth profiles 7.5 ¥ 10 4 for NCI-H 460, 1 ¥ 10 5 cells/ml for UACC-62, 1.5 ¥ 10 5 for MCF-7, SF-268 and TK-10) in 96-well plates and allowed to attach overnight. Cells were then exposed for 48 hr to serial concentrations of compounds and to the positive control doxorubicin. After the incubation period the adherent cells were fixed in situ, washed and stained with SRB. The bound stain was solubilized and the absorbance measured at 492 nm in a microplate reader. The concentration at inhibition of 50% of net cell growth (GI 50 ) was calculated as described elsewhere (Monks et al., 1991) . Toxicity was inferred from the SRB assay by comparing the absorbance of the wells containing treated cells after 48 hr with wells containing untreated cells fixed at the time at which compounds were added. Lower absorbances after 48 hr of treatment indicated occurrence of cell death instead of growth arrest. µm; SF-268 = 9.3 ð 0.7 ¥ 10 Ð2 µm; TK-10 = 57.0 ð 13.2 ¥ 10 Ð2 µm; UACC-62 = 9.4 t ð 2.3 ¥ 10 Ð2 µm. Results are means ð SEM of 3Ð6 independent observations performed in duplicate.
Results and Discussion
In vitro effects of six compounds from Subrerea aff. praetensa (Row) and their acetates on the growth of five human cancer cell lines are listed in Table II . Results are given in concentrations causing 50% cell growth inhibition. Inhibition was produced by several compounds. The effect produced by 1b and 4b appeared to be associated with real growth inhibition and not to cell death to toxicity, as inferred from the SRB assay. By contrast the effect produced by 4a seemed to be associated with toxicity because the number of cells remaining after 48 hr exposure was less than before addition of 4a. While 4b showed a modest inhibitory effect (GI 50 > 20 µm), 1b was a potent inhibitor of MCF-7, SF-268 and UACC-62 cancer cell lines (GI 50 < 10 µm).
